Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by Ziv Hospital
Sponsor:
Information provided by (Responsible Party):
Osamah Hussein, Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01215383
First received: October 4, 2010
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)